Premium
Virax Biolabs Group Ltd (VRAX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Fin d'année 31 Mars 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -6173.913 | -2066.667 | -3840.449 | -110.678 | -88.049 |
| Return on Equity (%) | 116.872 | 63.605 | 168.457 | -141.612 | -95.905 |
| Return on Invested Capital (%) | 107.16 | 62.921 | 170.922 | -148.774 | -86.961 |
| Operating Margin (%) | -649 | -519.355 | N/A | -60466.667 | -4302.564 |
| Net Profit Margin (%) | -710 | -525 | N/A | -60633.333 | -4316.667 |
| Book Value Per Share | -1.164 | -0.09 | -0.12 | 0.388 | 0.454 |
| Earnings Per Share | -0.68 | -0.071 | -0.171 | -0.243 | -0.594 |
| Cash Per Share | 0.022 | 0.002 | 0.002 | 0.416 | 0.317 |
| Working Capital Per Share | -1.164 | -0.09 | -0.12 | 0.388 | 0.372 |
| Operating Profit Per Share | 0.044 | -0.001 | N/A | N/A | 0.009 |
| EBIT Per Share | -0.708 | -0.073 | -0.175 | -0.243 | -0.595 |
| EBITDA Per Share | -0.708 | -0.073 | -0.175 | -0.243 | -0.595 |
| Free Cash Flow Per Share | -0.68 | -0.071 | -0.171 | -0.235 | -0.496 |
| Fin d'année 31 Mars 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | N/A | N/A | N/A | N/A | 2,57M |
| Fin d'année 31 Mars 2024 | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Actions en circulation | N/A | ||||
| Return on Assets (%) | N/A | ||||
| Return on Equity (%) | N/A | ||||
| Return on Invested Capital (%) | N/A | ||||
| Operating Margin (%) | N/A | ||||
| Net Profit Margin (%) | N/A | ||||
| Sales Per Share | N/A | ||||
| Book Value Per Share | N/A | ||||
| Earnings Per Share | N/A | ||||
| Cash Per Share | N/A | ||||
| Working Capital Per Share | N/A | ||||
| Operating Profit Per Share | N/A | ||||
| EBIT Per Share | N/A | ||||
| EBITDA Per Share | N/A | ||||
| Free Cash Flow Per Share | N/A | ||||
| Current Ratio | N/A | ||||
| Quick Ratio | N/A | ||||
| Inventory Turnover (Days) | N/A |
| Capitalisation boursière | 13,5M |
| Ratio cours/bénéfice | -1,79 |
| Ratio prix/ventes | 77,16 |
| Ratio prix/liquidités | 3,35 |
| Ratio prix/valeur comptable | 2,34 |
| Rendement de dividende | - |
| Actions en circulation | 4,34M |
| Volume moyen (1 semaine) | 1M |
| Volume moyen (1 mois) | 685,66k |
| Variation sur 52 semaines | 112,60% |
| Plus haut sur 52 semaines | 8,9999 |
| Plus bas sur 52 semaines | 0,60 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
